TP53 Mutation: Molecular Oncology Tumor Boards

This free case-based activity includes a crowd-sourced discussion of a 79-year-old male with an incidental finding of leukocytosis with lymphocytosis prior to elective knee replacement surgery in June of 2011. Originally posted on a forum in the ASCO Connection, participants now have the opportunity to claim CME, completion, or participation certificates for completing this activity.

Learning Objectives

  • Analyze treatment options for patients with chronic lymphocytic leukemia
  • Apply optimal treatment in patients with 17p13 deletion and TP53 mutation
  • Review the laboratory studies that are used to predict the prognosis of chronic lymphocytic leukemia patients at diagnosis
  • Discuss the role of targeted DNA sequence analysis in the evaluation and treatment of chronic lymphocytic leukemia patients

Continuing Education Credit

1 Credit/Point is available for participation in this course. Certificate and credit types available include:

  • AMA PRA Category 1 Credits™ 
  • Certificate of Participation may be used to confer credit; however, all final decisions regarding the awarding of credits will be made by the licensing organization to which the credits are submitted.
  • Certificate of Completion may be used to document participation, but no credit will be conferred.
Important Notes
  • This course expires on April 30, 2018. Participants must complete all necessary course components by this date to receive credit.